© 1993 by Oxford University Press
Journal of the National Cancer Institute, Vol. 85, No. 16, 1311-1318,
August 1993
© 1993 Oxford University Press
Screening for Colorectal Cancer With Fecal Occult Blood Testing and Sigmoidoscopy
Gastroenterology and Nutrition Service, Memorial Sloan-Kettering Cancer Center New York, N.Y.
Mathematical Sciences Department, IBM Research Division Yorktown Heights, N.Y.
Department of Epidemiology, School of Public Health, University of Michigan Ann Arbor, Mich.
Preventive Medicine Institute-Strang Clinic New York, N.Y.
Sidney J. Winawer, M.D., Gastroenterology and Nutrition Service, Memorial Sloan-Kettering Cancer Center, New Yorko, NY 10021.
Background: The high incidence of and mortality from colorectal cancer (160000 new cases and 60000 deaths in the United States each year) are compelling public health concerns. Following the evolution of effective surgery for this disease since the 1960s, the focus has been on improving methods of detection and integrating them into effective screening programs. Purpose: This was the first study to evaluate the effectiveness, in a setting of comprehensive medical examinations, of using the fecal occult blood test in conjunction with sigmoidoscopy, rather than sigmoidoscopy alone, to screen for colorectal cancer. Our end points were extent of compliance with fecal occult blood test and sigmoidoscopy, numbers of cancers detected, and mortality rate. Methods: From 1975 through 1979, a total of 21756 patients (aged 40 and older) who presented at the Preventive Medicine Institute—Strang Clinic for routine medical examinations were enrolled by calendar period into study and control groups. Study patients were offered annually both rigid sigmoidoscopy examinations and fecal occult blood tests requiring two stool specimens per day for 3 days, while control patients were offered only annual sigmoidoscopy. The majority of fecal occult blood tests cards were not rehydrated before assay. Patients with positive tests were referred for double-contrast barium enema and colonoscopy. Two distinct trials were carried out. Trial I was primarily a demonstration of feasibility of using the fecal occult blood test as a supplemental screening method. Of the 9277 participants, 7168 (77%) were assigned to the study group and offered the fecal occult blood test. In trial II, approximately half of the 12479 patients were assigned to each group. Patients in both trials had followup through 1984. Results: Compliance with the fecal occult blood test was initially high in both trials, but diminished such that only 56% of study patients in trial I and 20% of those in trial II returned for second tests. On the initial (prevalence) screen, a substantial number of early-stage cancers were detected by the fecal occult blood test, primarily in trial II. In trial II, survival probability was significantly greater (P<.001) in the study group than in the controls (70% versus 48%), and colorectal cancer mortality was lower (0.36 versus 0.63) with borderline significance (P = .053, one-sided). Conclusions and Implications: The screening of averagerisk individuals (aged 50 and older) for colorectal cancer through use of the fecal occult blood test in conjunction with sigmoidoscopy can increase the likelihood of early detection of this disease. This practice, coupled with prompt diagnostic work-up following positive tests, will result in treatment of earlier stage cancers and increased survival after treatment. [J Natl Cancer Inst 85:1311–1318, 1993]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. L. Lewis, C. G. Moore, C. E. Golin, J. Griffith, A. Tytell-Brenner, and M. P. Pignone Resident Physicians' Life Expectancy Estimates and Colon Cancer Screening Recommendations in Elderly Patients Med Decis Making, April 1, 2008; 28(2): 254 - 261. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Sosna, T. Sella, O. Sy, P. T. Lavin, R. Eliahou, S. Fraifeld, and E. Libson Critical Analysis of the Performance of Double-Contrast Barium Enema for Detecting Colorectal Polyps >= 6 mm in the Era of CT Colonography Am. J. Roentgenol., February 1, 2008; 190(2): 374 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zou, J. J. Harrington, A. M. Shire, R. L. Rego, L. Wang, M. E. Campbell, A. L. Oberg, and D. A. Ahlquist Highly Methylated Genes in Colorectal Neoplasia: Implications for Screening Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2686 - 2696. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Colquhoun, E. G. Weiss, J. Efron, J. J. Nogueras, A. M. Vernava III, and S. D. Wexner Colorectal cancer screening: do we practice what we preach? Surgical Innovation, June 1, 2006; 13(2): 81 - 85. [Abstract] [PDF]
|
|
|
|
 |
|
 S. L. Gearhart, D. Frassica, R. Rosen, M. Choti, R. Schulick, and R. Wahl Improved Staging With Pretreatment Positron Emission Tomography/Computed Tomography in Low Rectal Cancer Ann. Surg. Oncol., March 1, 2006; 13(3): 397 - 404. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. R. Yabroff, C. N. Klabunde, R. Myers, and M. L. Brown Physician Recommendations for Follow-Up of Positive Fecal Occult Blood Tests Med Care Res Rev, February 1, 2005; 62(1): 79 - 110. [Abstract] [PDF]
|
|
|
|
|
|
A. C. Battat, R. V. Rouse, L. Dempsey, B. Y. Safadi, and S. M. Wren Institutional Commitment to Rectal Cancer Screening Results in Earlier-Stage Cancers on Diagnosis Ann. Surg. Oncol., November 1, 2004; 11(11): 970 - 976. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Provenzale and R. N. Gray Colorectal Cancer Screening and Treatment: Review of Outcomes Research J Natl Cancer Inst Monographs, October 1, 2004; 2004(33): 45 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. R. Church, M. W. Yeazel, R. M. Jones, L. K. Kochevar, G. D. Watt, S. J. Mongin, J. E. Cordes, and D. Engelhard A Randomized Trial of Direct Mailing of Fecal Occult Blood Tests To Increase Colorectal Cancer Screening J Natl Cancer Inst, May 19, 2004; 96(10): 770 - 780. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. R. Yabroff, N. Breen, S. W. Vernon, H. I. Meissner, A. N. Freedman, and R. Ballard-Barbash What Factors Are Associated with Diagnostic Follow-Up after Abnormal Mammograms? Findings from a U.S. National Survey Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 723 - 732. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. T. Hawley, S. W. Vernon, B. Levin, and B. Vallejo Prevalence of Colorectal Cancer Screening in a Large Medical Organization Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 314 - 319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. R. Yabroff, K. S. Washington, A. Leader, E. Neilson, and J. Mandelblatt Is the Promise of Cancer-Screening Programs Being Compromised? Quality of Follow-Up Care after Abnormal Screening Results Med Care Res Rev, September 1, 2003; 60(3): 294 - 331. [Abstract] [PDF]
|
|
|
|
 |
|
 J. M. Trauth, B. S. Ling, J. L. Weissfeld, R. E. Schoen, and M. Hayran Using the Transtheoretical Model to Stage Screening Behavior for Colorectal Cancer Health Educ Behav, June 1, 2003; 30(3): 322 - 336. [Abstract] [PDF]
|
|
|
|
|
|
J. S. Mandel Sigmoidoscopy Screening Probably Works, but How Well Is Still Unknown J Natl Cancer Inst, April 16, 2003; 95(8): 571 - 573. [Full Text] [PDF]
|
|
|
|
|
|
B. G. Watts, S. W. Vernon, R. E. Myers, and B. C. Tilley Intention to be Screened Over Time for Colorectal Cancer in Male Automotive Workers Cancer Epidemiol. Biomarkers Prev., April 1, 2003; 12(4): 339 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. E. Walsh and J. P. Terdiman Colorectal Cancer Screening: Scientific Review JAMA, March 12, 2003; 289(10): 1288 - 1296. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. Gatto, H. Frucht, V. Sundararajan, J. S. Jacobson, V. R. Grann, and A. I. Neugut Risk of Perforation After Colonoscopy and Sigmoidoscopy: A Population-Based Study J Natl Cancer Inst, February 5, 2003; 95(3): 230 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. NICOLLIER-FAHRNI, J.-P. VADER, F. FROEHLICH, J.-J. GONVERS, and B. BURNAND Development of appropriateness criteria for colonoscopy: comparison between a standardized expert panel and an evidence-based medicine approach Int. J. Qual. Health Care, February 1, 2003; 15(1): 15 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. F. Anderson, K. Z. Guyton, R. A. Hiatt, S. W. Vernon, B. Levin, and E. Hawk Colorectal Cancer Screening for Persons at Average Risk J Natl Cancer Inst, August 7, 2002; 94(15): 1126 - 1133. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pignone, M. Rich, S. M. Teutsch, A. O. Berg, and K. N. Lohr Screening for Colorectal Cancer in Adults at Average Risk: A Summary of the Evidence for the U.S. Preventive Services Task Force Ann Intern Med, July 16, 2002; 137(2): 132 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. D. Andersen, P. Remington, A. Trentham-Dietz, and M. Reeves Assessing a Decade of Progress in Cancer Control Oncologist, June 1, 2002; 7(3): 200 - 204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. La Vecchia Fecal occult blood screening for colorectal cancer: open issues Ann. Onc., January 19, 2002; 13(1): 31 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Lowenfels Fecal occult blood testing as a screening procedure for colorectal cancer Ann. Onc., January 19, 2002; 13(1): 40 - 43. [Full Text] [PDF]
|
|
|
|
|
|
M. Crespi and D. Lisi Is colorectal cancer screening by fecal occult blood feasible? Ann. Onc., January 19, 2002; 13(1): 47 - 50. [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Winawer A Quarter Century of Colorectal Cancer Screening: Progress and Prospects J. Clin. Oncol., September 15, 2001; 19(90001): 6s - 12. [Full Text] [PDF]
|
|
|
|
 |
|
 J Tibble, G Sigthorsson, R Foster, R Sherwood, M Fagerhol, and I Bjarnason Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma Gut, September 1, 2001; 49(3): 402 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Lieberman, W. V. Harford, D. J. Ahnen, D. Provenzale, S. J. Sontag, T. G. Schnell, G. Chejfec, D. R. Campbell, T. E. Durbin, J. H. Bond, et al. One-Time Screening for Colorectal Cancer with Combined Fecal Occult-Blood Testing and Examination of the Distal Colon N. Engl. J. Med., August 23, 2001; 345(8): 555 - 560. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F Citarda, G Tomaselli, R Capocaccia, S Barcherini, M Crespi, and T. I. M. S. Group Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence Gut, June 1, 2001; 48(6): 812 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. McMahon, J. L. Bosch, S. Gleason, E. F. Halpern, J. S. Lester, and G. S. Gazelle Cost-Effectiveness of Colorectal Cancer Screening Radiology, April 1, 2001; 219(1): 44 - 50. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. A. Smith, A. C. von Eschenbach, R. Wender, B. Levin, T. Byers, D. Rothenberger, D. Brooks, W. Creasman, C. Cohen, C. Runowicz, et al. American Cancer Society Guidelines for the Early Detection of Cancer: Update of Early Detection Guidelines for Prostate, Colorectal, and Endometrial Cancers: ALSO: Update 2001--Testing for Early Lung Cancer Detection CA Cancer J Clin, January 1, 2001; 51(1): 38 - 75. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Mandel, T. R. Church, J. H. Bond, F. Ederer, M. S. Geisser, S. J. Mongin, D. C. Snover, and L. M. Schuman The Effect of Fecal Occult-Blood Screening on the Incidence of Colorectal Cancer N. Engl. J. Med., November 30, 2000; 343(22): 1603 - 1607. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Winawer and A. G. Zauber Colorectal cancer screening: Now is the time Can. Med. Assoc. J., September 1, 2000; 163(5): 543 - 544. [Full Text] [PDF]
|
|
|
|
|
|
C. D. Johnson and A. H. Dachman CT Colonography: The Next Colon Screening Examination? Radiology, August 1, 2000; 216(2): 331 - 341. [Abstract] [Full Text]
|
|
|
|
|
|
S. Glick Double-Contrast Barium Enema for Colorectal Cancer Screening: A Review of the Issues and a Comparison with Other Screening Alternatives Am. J. Roentgenol., June 1, 2000; 174(6): 1529 - 1537. [Full Text]
|
|
|
|
|
|
H. M. Fenlon, D. P. Nunes, P. C. Schroy, M. A. Barish, P. D. Clarke, and J. T. Ferrucci A Comparison of Virtual and Conventional Colonoscopy for the Detection of Colorectal Polyps N. Engl. J. Med., November 11, 1999; 341(20): 1496 - 1503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Bond Improving the Effectiveness of Fecal Occult Blood Screening for Colorectal Cancer J Natl Cancer Inst, October 6, 1999; 91(19): 1602 - 1603. [Full Text] [PDF]
|
|
|
|
|
|
D. C. Rockey Occult Gastrointestinal Bleeding N. Engl. J. Med., July 1, 1999; 341(1): 38 - 46. [Full Text] [PDF]
|
|
|
|
|
|
C D JOHNSON and D A AHLQUIST Computed tomography colonography (virtual colonoscopy): a new method for colorectal screening Gut, March 1, 1999; 44(3): 301 - 305. [Full Text] [PDF]
|
|
|
|
 |
|
 B. Towler, L. Irwig, P. Glasziou, J. Kewenter, D. Weller, and C. Silagy A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult BMJ, August 29, 1998; 317(7158): 559 - 565. [Abstract] [Full Text]
|
|
|
|
|
|
J. E. Allison, I. S. Tekawa, L. J. Ransom, and A. L. Adrain A Comparison of Fecal Occult-Blood Tests for Colorectal-Cancer Screening N. Engl. J. Med., January 18, 1996; 334(3): 155 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. W. Toribara and M. H. Sleisenger Screening for Colorectal Cancer N. Engl. J. Med., March 30, 1995; 332(13): 861 - 867. [Full Text] [PDF]
|
|
|
|
|
|
S. J. Winawer, A. G. Zauber, M. N. Ho, M. J. O'Brien, L. S. Gottlieb, S. S. Sternberg, J. D. Waye, M. Schapiro, J. H. Bond, J. F. Panish, et al. Prevention of Colorectal Cancer by Colonoscopic Polypectomy N. Engl. J. Med., December 30, 1993; 329(27): 1977 - 1981. [Abstract] [Full Text]
|
|